World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
71
Citations
16379
World Ranking
6721
National Ranking
3118

Robert Hromas publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Robert Hromas sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 229 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Robert Hromas D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Robert Hromas sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Robert Hromas is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their research covers multiple areas primarily within biochemistry, genetics, and molecular biology, with a significant focus on medicine.

The scientist's extensive publication record includes 106 works in the main field of Biochemistry, Genetics and Molecular Biology and 51 works in Medicine. Subfields of study include Molecular Biology, Oncology, Cancer Research, Hematology, and Immunology.

Key topics in their research are:

  • DNA Repair Mechanisms
  • PARP inhibition in cancer therapy
  • CRISPR and Genetic Engineering
  • Protein Degradation and Inhibitors
  • Ubiquitin and proteasome pathways
  • RNA modifications and cancer
  • Peptidase Inhibition and Analysis

The scientist has published multiple papers in notable journals, including Nature Communications, Cancer Research, Journal of Clinical Oncology, and Molecular Cancer Therapeutics. Frequent publication venues include:

  • Nature Communications (6 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (5 publications)
  • Cancer Research (4 publications)
  • Journal of Clinical Oncology (3 publications)
  • Molecular Cancer Therapeutics (2 publications)

Some recent papers authored or co-authored by Robert Hromas are:

  • Structural basis of RNA cap modification by SARS-CoV-2, 2020, Nature Communications
  • Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity, 2021, Nature Communications
  • Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies, 2020, Journal of Hematology & Oncology
  • M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression, 2022, Cancer Research
  • Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL-Specific Degrader DT2216, 2021, Molecular Cancer Therapeutics

Robert Hromas has frequently collaborated with several researchers. The most frequent co-authors are:

  • Daohong Zhou (21 collaborations)
  • Patrick Sung (16 collaborations)
  • Elizabeth A. Williamson (15 collaborations)
  • Weixing Zhao (10 collaborations)
  • Sandeep Burma (10 collaborations)

They have been recognized as a member of the Association of American Physicians. This membership signifies an acknowledgment within the medical and scientific community.

Best Publications

  • Transcription factors, normal myeloid development, and leukemia.

    Daniel G. Tenen;Robert Hromas;Jonathan D. Licht;Dong-Er Zhang

  • The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.

    William A. May;Stephen L. Lessnick;Benjamin S. Braun;Michael Klemsz

  • Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production.

    Trevor Starnes;Michael J. Robertson;George Sledge;Stephanie Kelich

  • Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis.

    Trevor Starnes;Hal E. Broxmeyer;Michael J. Robertson;Robert A Hromas

  • A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity

    Sajid Khan;Xuan Zhang;Dongwen Lv;Qi Zhang

  • Drug Repurposing from an Academic Perspective.

    Tudor I. Oprea;Julie E. Bauman;Cristian G. Bologa;Tione Buranda

  • Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining

    Sheema Fnu;Elizabeth A. Williamson;Leyma P. De Haro;Mark Brenneman

  • Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.

    Rafat Abonour;David A. Williams;Lawrence Einhorn;Kristin M. Hall

  • PLAB, a novel placental bone morphogenetic protein.

    Robert Hromas;Matthew Hufford;Jill Sutton;Dawei Xu

  • Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1

    R Hromas;A Orazi;RS Neiman;R Maki

  • A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells.

    R Hromas;S J Collins;D Hickstein;W Raskind

  • Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells.

    Jill Sutton;Robert Costa;Michael Klug;Loren Field

  • Cloning of BRAK, a Novel Divergent CXC Chemokine Preferentially Expressed in Normal versus Malignant Cells

    Robert Hromas;Hal E. Broxmeyer;Chang Kim;Harikrishna Nakshatri

  • Synthetic lethality: exploiting the addiction of cancer to DNA repair

    Montaser Shaheen;Christopher Allen;Jac A. Nickoloff;Robert A Hromas

  • Cloning and Characterization of Exodus, a Novel β-Chemokine

    Robert Hromas;Patrick W. Gray;David Chantry;Ronald Godiska

  • Structural basis of RNA cap modification by SARS-CoV-2.

    Thiruselvam Viswanathan;Shailee Arya;Shailee Arya;Siu Hong Chan;Shan Qi;Shan Qi

  • Update on Late Relapse of Germ Cell Tumor: A Clinical and Molecular Analysis

    David W. George;Richard S. Foster;Robert A. Hromas;Robert A. Hromas;Kent A. Robertson

  • The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression

    Ying Guo;Robert Costa;Heather Ramsey;Trevor Starnes

  • The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair

    Suk Hee Lee;Masahiko Oshige;Stephen T. Durant;Kanwaldeep Kaur Rasila

  • Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension.

    Robert Hromas;Chang H. Kim;Michael Klemsz;Mitchell Krathwohl

Frequent Co-Authors

Elizabeth A. Williamson
Elizabeth A. Williamson London School of Hygiene & Tropical Medicine
Hal E. Broxmeyer
Hal E. Broxmeyer Indiana University
Jac A. Nickoloff
Jac A. Nickoloff Colorado State University
Kenneth Cornetta
Kenneth Cornetta Indiana University
Patrick Sung
Patrick Sung The University of Texas Health Science Center at San Antonio
Edward F. Srour
Edward F. Srour Indiana University
Daohong Zhou
Daohong Zhou University of Florida
Chang H. Kim
Chang H. Kim University of Michigan–Ann Arbor
Larry A. Sklar
Larry A. Sklar University of New Mexico
Cheryl L. Willman
Cheryl L. Willman University of New Mexico

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in Biology and Biochemistry opens many doors in healthcare, research, and allied fields. Many students choose unique pathways that complement their scientific background. For example, completing psychiatric np programs online can complement biochemistry knowledge with mental health expertise, providing a pathway to advanced nursing roles.

Nutrition is another fast-growing field. Those seeking to work in wellness or dietetics may consider an accelerated nutrition degree online, which can quickly build specialized qualifications for emerging careers in diet management and public health.

Careers in healthcare management are also popular, with flexible options like the healthcare mba cost being a key factor for prospective students. Affordable MBA programs allow graduates to move into administrative or leadership roles within healthcare settings.

Certification is important, too. For those drawn toward healthcare information management, understanding the differences and prospects of ccs vs cpc certification can help in choosing a coding certification that aligns with your career ambitions and salary expectations.

Best Scientists Citing Robert Hromas

Trending Scientists